[Skip to Navigation]
Sign In

Year

Day

November 30, 2023
Original Investigation

Topical Atropine for Childhood Myopia Control: The Atropine Treatment Long-Term Assessment Study

Abstract Full Text
JAMA Ophthalmol. Published online November 30, 2023. doi:10.1001/jamaophthalmol.2023.5467

This study reports long-term safety and outcomes of topical atropine for childhood myopia control.

Brief Report

Metformin Use and Age-Related Macular Degeneration in Patients Without Diabetes

Abstract Full Text
JAMA Ophthalmol. Published online November 30, 2023. doi:10.1001/jamaophthalmol.2023.5478

This case-control study uses data from a nationwide claims database to investigate the risk of developing age-related macular degeneration in patients without diabetes who take metformin.

Invited Commentary

Atropine Eye Drops for Myopia Control in Childhood—More Long-Term Data, Please

Abstract Full Text
JAMA Ophthalmol. Published online November 30, 2023. doi:10.1001/jamaophthalmol.2023.5610
Comment & Response

Sociodemographic Characteristics Distinguished From Social Determinants of Health

Abstract Full Text
JAMA Ophthalmol. Published online November 30, 2023. doi:10.1001/jamaophthalmol.2023.5383
November 22, 2023
Viewpoint

Genetic Counseling For Predictive Retinal Imaging

Abstract Full Text
JAMA Ophthalmol. Published online November 22, 2023. doi:10.1001/jamaophthalmol.2023.5329

This Viewpoint discusses genetic counseling for predictive retinal imaging.

Original Investigation

Rising Incidence of Syphilitic Uveitis–Related Hospitalizations in the US

Abstract Full Text
JAMA Ophthalmol. Published online November 22, 2023. doi:10.1001/jamaophthalmol.2023.5386

This cross-sectional study uses patient data from the Nationwide Inpatient Sample to investigate the national and regional incidence of syphilitic uveitis in the US from 2010 to 2019.

November 16, 2023
Original Investigation

Efficacy and Safety of Brolucizumab for Diabetic Macular Edema: The KINGFISHER Randomized Clinical Trial

Abstract Full Text
open access
JAMA Ophthalmol. Published online November 16, 2023. doi:10.1001/jamaophthalmol.2023.5248

This randomized clinical trial evaluates the efficacy and safety of brolucizumab vs aflibercept dosed every 4 weeks in participants with diabetic macular edema.

Social Determinants of Health and Perceived Barriers to Care in Diabetic Retinopathy Screening

Abstract Full Text
has audio
JAMA Ophthalmol. Published online November 16, 2023. doi:10.1001/jamaophthalmol.2023.5287

This cross-sectional study examines the factors related to social determinants of health that are associated with visiting an eye care practitioner among patients with type 2 diabetes.

Brief Report

Surgical Approach and Reoperation Risk in Intermittent Exotropia in the IRIS Registry

Abstract Full Text
JAMA Ophthalmol. Published online November 16, 2023. doi:10.1001/jamaophthalmol.2023.5288

This cohort study examines the risk of reoperation in children with intermittent exotropia associated with bilateral lateral rectus recession compared with unilateral lateral rectus recession with medial rectus resection.

November 9, 2023
Original Investigation

Psychiatric Comorbidities Associated With Keratoconus

Abstract Full Text
JAMA Ophthalmol. Published online November 9, 2023. doi:10.1001/jamaophthalmol.2023.5176

This cross-sectional study assesses whether risk for keratoconus is higher in adolescents and adults with psychiatric comorbidities.

Invited Commentary

Do Not Think of a Purple Wolf—Keratoconus, ADHD, and Itch

Abstract Full Text
JAMA Ophthalmol. Published online November 9, 2023. doi:10.1001/jamaophthalmol.2023.5283
Research Letter

Intraocular Pressure in Eyes With Retinal Vein Occlusion Compared With Fellow Eyes: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 27

Abstract Full Text
JAMA Ophthalmol. Published online November 9, 2023. doi:10.1001/jamaophthalmol.2023.5159

This cohort study investigates intraocular pressure (IOP) in eyes with retinal vein occlusion (RVO) compared with fellow, unaffected eyes.

Large Language Model Advanced Data Analysis Abuse to Create a Fake Data Set in Medical Research

Abstract Full Text
JAMA Ophthalmol. Published online November 9, 2023. doi:10.1001/jamaophthalmol.2023.5162

This quality improvement study evaluates the ability of GPT-4 Advanced Data Analysis to create a fake data set that can be used for the purpose of scientific research.

Comment & Response

Risk of New Retinal Vascular Occlusion After Messenger RNA COVID-19 Vaccination Within Aggregated Electronic Health Record Data

Abstract Full Text
free access
JAMA Ophthalmol. Published online November 9, 2023. doi:10.1001/jamaophthalmol.2023.5076

Risk of New Retinal Vascular Occlusion After Messenger RNA COVID-19 Vaccination Within Aggregated Electronic Health Record Data

Abstract Full Text
free access
JAMA Ophthalmol. Published online November 9, 2023. doi:10.1001/jamaophthalmol.2023.5079

Risk of New Retinal Vascular Occlusion After Messenger RNA COVID-19 Vaccination Within Aggregated Electronic Health Record Data

Abstract Full Text
free access
JAMA Ophthalmol. Published online November 9, 2023. doi:10.1001/jamaophthalmol.2023.5082

Risk of New Retinal Vascular Occlusion After Messenger RNA COVID-19 Vaccination Within Aggregated Electronic Health Record Data—Reply

Abstract Full Text
free access
JAMA Ophthalmol. Published online November 9, 2023. doi:10.1001/jamaophthalmol.2023.5085
November 2, 2023
Viewpoint

Regulatory and Informational Gaps in the Over-the-Counter Eye Care Product Industry—Over the Counter, Under the Radar

Abstract Full Text
JAMA Ophthalmol. Published online November 2, 2023. doi:10.1001/jamaophthalmol.2023.4961

This Viewpoint describes the limitations of regulatory oversight for over-the-counter eye care products and challenges in providing clinical recommendations.

Original Investigation

Pathogen Surveillance for Acute Infectious Conjunctivitis

Abstract Full Text
JAMA Ophthalmol. Published online November 2, 2023. doi:10.1001/jamaophthalmol.2023.4785

This cross-sectional study examines the microbial etiologies of acute infectious conjunctivitis at 4 sites in the US and 1 site in Israel.

Incidence and Risk Factors for Neutropenia After Intra-Arterial Chemotherapy for Retinoblastoma

Abstract Full Text
JAMA Ophthalmol. Published online November 2, 2023. doi:10.1001/jamaophthalmol.2023.4825

This case series examines the incidence of neutropenia after intra-arterial chemotherapy in pediatric patients with retinoblastoma and risk factors for disease occurrence.

Invited Commentary

Fever and Neutropenia Can Be a Risk to the Child’s Life

Abstract Full Text
JAMA Ophthalmol. Published online November 2, 2023. doi:10.1001/jamaophthalmol.2023.4840
×